Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IMULAN BioTherapeutics
Prescott, Arizona, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Imulan BioTherapeutics was a biotechnology company specializing in the development of immunotherapies and regenerative medicine for veterinary health. The company is best known for developing the Lymphocyte T-Cell Immunomodulator (LTCI), the first USDA-approved treatment for cats infected with Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV). Beyond feline health, Imulan focused on immune-mediated conditions in dogs, including atopic dermatitis and osteoarthritis. The company's approach leveraged biological response modifiers to enhance the host's immune system. In January 2011, Imulan was acquired by Heska Corporation, a leading provider of veterinary diagnostic and specialty products.
- Therapeutic areas
- RheumatologyDermatologyInfectious Diseases
- Modalities
- BiologicProteinPeptidesStem cell therapy
- Industry
- Veterinary
Beyond the preview
Go deeper on IMULAN BioTherapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IMULAN BioTherapeutics.